Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (191-200 of 308) with videos related to

Pageof 31
Sort By:
Trials|June 20, 2021
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trialMaike H M Wientjes, Sadaf Atiqi, Gerrit Jan Wolbink, et al.
RMD Open|February 27, 2024
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trialCarlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, et al.
Arthritis Care & Research|April 21, 2025
Two-Year Follow-Up of a Multidisciplinary Lifestyle Intervention for Rheumatoid Arthritis and OsteoarthritisCarlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, et al.
The Journal of Rheumatology|April 5, 2007
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?Désirée van der Heijde, Robert Landewé, Kay-Geert Hermann, et al.
The Journal of Rheumatology|March 9, 2007
Assessing single joints in arthritis clinical trialsJon T Giles, Philip Mease, Maarten Boers, et al.
Arthritis and Rheumatism|July 13, 2004
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysisPaco M J Welsing, Robert B M Landewé, Piet L C M van Riel, et al.
JMIR Research Protocols|March 5, 2020
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled TrialBart F Seppen, Merel J L'ami, Sharon Duarte Dos Santos Rico, et al.
Arthritis Research & Therapy|September 26, 2015
Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory studyYoony Y J Gent, Marieke M Ter Wee, Alexandre E Voskuyl, et al.
Arthritis and Rheumatism|January 30, 2010
The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazineRonald F van Vollenhoven, Jos G A Houbiers, Frank Buttgereit, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
Pageof 31

Showing results (191-200 of 308) with videos related to

Sort By:
Pageof 31
Trials|June 20, 2021
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trialMaike H M Wientjes, Sadaf Atiqi, Gerrit Jan Wolbink, et al.
RMD Open|February 27, 2024
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trialCarlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, et al.
Arthritis Care & Research|April 21, 2025
Two-Year Follow-Up of a Multidisciplinary Lifestyle Intervention for Rheumatoid Arthritis and OsteoarthritisCarlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, et al.
The Journal of Rheumatology|April 5, 2007
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?Désirée van der Heijde, Robert Landewé, Kay-Geert Hermann, et al.
The Journal of Rheumatology|March 9, 2007
Assessing single joints in arthritis clinical trialsJon T Giles, Philip Mease, Maarten Boers, et al.
Arthritis and Rheumatism|July 13, 2004
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysisPaco M J Welsing, Robert B M Landewé, Piet L C M van Riel, et al.
JMIR Research Protocols|March 5, 2020
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled TrialBart F Seppen, Merel J L'ami, Sharon Duarte Dos Santos Rico, et al.
Arthritis Research & Therapy|September 26, 2015
Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory studyYoony Y J Gent, Marieke M Ter Wee, Alexandre E Voskuyl, et al.
Arthritis and Rheumatism|January 30, 2010
The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazineRonald F van Vollenhoven, Jos G A Houbiers, Frank Buttgereit, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
Pageof 31